Christiaan de Bruin1, Verónica Mericq, Shayne F Andrew, Hermine A van Duyvenvoorde, Nicole S Verkaik, Monique Losekoot, Aleksey Porollo, Hernán Garcia, Yi Kuang, Dan Hanson, Peter Clayton, Dik C van Gent, Jan M Wit, Vivian Hwa, Andrew Dauber. 1. Cincinnati Center for Growth Disorders (C.d.B., S.F.A., V.H., A.D.), Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229; Institute of Maternal and Child Research (V.M.), Faculty of Medicine, University of Chile, 226-3 Santiago, Chile; Laboratory for Diagnostic Genome Analysis (H.A.v.D., M.L.), Department of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; Department of Genetics (N.S.V., D.C.v.G.), Erasmus MC, 3015 CE Rotterdam, The Netherlands; Center for Autoimmune Genomics and Etiology (A.P.), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229; Pediatrics Division (H.G.), Faculty of Medicine, Pontificia Universidad Catolica de Chile Santiago, 340 Santiago, Chile; Division of Developmental Biology (Y.K.), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229; Institute of Human Development (D.H., P.C.), University of Manchester and Manchester Academic Health Sciences Centre, Manchester M13 9PL, United Kingdom; and Department of Pediatrics (J.M.W.), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Abstract
CONTEXT: Severe short stature can be caused by defects in numerous biological processes including defects in IGF-1 signaling, centromere function, cell cycle control, and DNA damage repair. Many syndromic causes of short stature are associated with medical comorbidities including hypogonadism and microcephaly. OBJECTIVE: To identify an underlying genetic etiology in two siblings with severe short stature and gonadal failure. DESIGN: Clinical phenotyping, genetic analysis, complemented by in vitro functional studies of the candidate gene. SETTING: An academic pediatric endocrinology clinic. PATIENTS OR OTHER PARTICIPANTS: Two adult siblings (male patient [P1] and female patient 2 [P2]) presented with a history of severe postnatal growth failure (adult heights: P1, -6.8 SD score; P2, -4 SD score), microcephaly, primary gonadal failure, and early-onset metabolic syndrome in late adolescence. In addition, P2 developed a malignant gastrointestinal stromal tumor at age 28. INTERVENTION(S): Single nucleotide polymorphism microarray and exome sequencing. RESULTS: Combined microarray analysis and whole exome sequencing of the two affected siblings and one unaffected sister identified a homozygous variant in XRCC4 as the probable candidate variant. Sanger sequencing and mRNA studies revealed a splice variant resulting in an in-frame deletion of 23 amino acids. Primary fibroblasts (P1) showed a DNA damage repair defect. CONCLUSIONS: In this study we have identified a novel pathogenic variant in XRCC4, a gene that plays a critical role in non-homologous end-joining DNA repair. This finding expands the spectrum of DNA damage repair syndromes to include XRCC4 deficiency causing severe postnatal growth failure, microcephaly, gonadal failure, metabolic syndrome, and possibly tumor predisposition.
CONTEXT: Severe short stature can be caused by defects in numerous biological processes including defects in IGF-1 signaling, centromere function, cell cycle control, and DNA damage repair. Many syndromic causes of short stature are associated with medical comorbidities including hypogonadism and microcephaly. OBJECTIVE: To identify an underlying genetic etiology in two siblings with severe short stature and gonadal failure. DESIGN: Clinical phenotyping, genetic analysis, complemented by in vitro functional studies of the candidate gene. SETTING: An academic pediatric endocrinology clinic. PATIENTS OR OTHER PARTICIPANTS: Two adult siblings (male patient [P1] and female patient 2 [P2]) presented with a history of severe postnatal growth failure (adult heights: P1, -6.8 SD score; P2, -4 SD score), microcephaly, primary gonadal failure, and early-onset metabolic syndrome in late adolescence. In addition, P2 developed a malignant gastrointestinal stromal tumor at age 28. INTERVENTION(S): Single nucleotide polymorphism microarray and exome sequencing. RESULTS: Combined microarray analysis and whole exome sequencing of the two affected siblings and one unaffected sister identified a homozygous variant in XRCC4 as the probable candidate variant. Sanger sequencing and mRNA studies revealed a splice variant resulting in an in-frame deletion of 23 amino acids. Primary fibroblasts (P1) showed a DNA damage repair defect. CONCLUSIONS: In this study we have identified a novel pathogenic variant in XRCC4, a gene that plays a critical role in non-homologous end-joining DNA repair. This finding expands the spectrum of DNA damage repair syndromes to include XRCC4 deficiency causing severe postnatal growth failure, microcephaly, gonadal failure, metabolic syndrome, and possibly tumor predisposition.
Authors: M Takata; M S Sasaki; E Sonoda; C Morrison; M Hashimoto; H Utsumi; Y Yamaguchi-Iwai; A Shinohara; S Takeda Journal: EMBO J Date: 1998-09-15 Impact factor: 11.598
Authors: Louise S Bicknell; Sarah Walker; Anna Klingseisen; Tom Stiff; Andrea Leitch; Claudia Kerzendorfer; Carol-Anne Martin; Patricia Yeyati; Nouriya Al Sanna; Michael Bober; Diana Johnson; Carol Wise; Andrew P Jackson; Mark O'Driscoll; Penny A Jeggo Journal: Nat Genet Date: 2011-02-27 Impact factor: 38.330
Authors: Mirjam van der Burg; Lieneke R van Veelen; Nicole S Verkaik; Wouter W Wiegant; Nico G Hartwig; Barbara H Barendregt; Linda Brugmans; Anja Raams; Nicolaas G J Jaspers; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent Journal: J Clin Invest Date: 2005-12-15 Impact factor: 14.808
Authors: Louise S Bicknell; Ernie M H F Bongers; Andrea Leitch; Stephen Brown; Jeroen Schoots; Margaret E Harley; Salim Aftimos; Jumana Y Al-Aama; Michael Bober; Paul A J Brown; Hans van Bokhoven; John Dean; Alaa Y Edrees; Murray Feingold; Alan Fryer; Lies H Hoefsloot; Nikolaus Kau; Nine V A M Knoers; James Mackenzie; John M Opitz; Pierre Sarda; Alison Ross; I Karen Temple; Annick Toutain; Carol A Wise; Michael Wright; Andrew P Jackson Journal: Nat Genet Date: 2011-02-27 Impact factor: 38.330
Authors: Per Qvist; Pablo Huertas; Sonia Jimeno; Mette Nyegaard; Muhammad J Hassan; Stephen P Jackson; Anders D Børglum Journal: PLoS Genet Date: 2011-10-06 Impact factor: 5.917
Authors: Michal Hammel; Martial Rey; Yaping Yu; Rajam S Mani; Scott Classen; Mona Liu; Michael E Pique; Shujuan Fang; Brandi L Mahaney; Michael Weinfeld; David C Schriemer; Susan P Lees-Miller; John A Tainer Journal: J Biol Chem Date: 2011-07-20 Impact factor: 5.157
Authors: Illja J Diets; Roos van der Donk; Kristina Baltrunaite; Esmé Waanders; Margot R F Reijnders; Alexander J M Dingemans; Rolph Pfundt; Anneke T Vulto-van Silfhout; Laurens Wiel; Christian Gilissen; Julien Thevenon; Laurence Perrin; Alexandra Afenjar; Caroline Nava; Boris Keren; Sarah Bartz; Bethany Peri; Gea Beunders; Nienke Verbeek; Koen van Gassen; Isabelle Thiffault; Maxime Cadieux-Dion; Lina Huerta-Saenz; Matias Wagner; Vassiliki Konstantopoulou; Julia Vodopiutz; Matthias Griese; Annekatrien Boel; Bert Callewaert; Han G Brunner; Tjitske Kleefstra; Nicoline Hoogerbrugge; Bert B A de Vries; Vivian Hwa; Andrew Dauber; Jayne Y Hehir-Kwa; Roland P Kuiper; Marjolijn C J Jongmans Journal: Am J Hum Genet Date: 2019-03-28 Impact factor: 11.025
Authors: Meghan E Fredette; Kristin C Lombardi; Angela L Duker; Catherine O Buck; Chanika Phornphutkul; Michael B Bober; Jose Bernardo Quintos Journal: AACE Clin Case Rep Date: 2019-08-28
Authors: Anie Day D C Asa; Rujira Wanotayan; Mukesh Kumar Sharma; Kaima Tsukada; Mikio Shimada; Yoshihisa Matsumoto Journal: J Radiat Res Date: 2021-05-12 Impact factor: 2.724